Scleroderma Program

Physician-scientists in the Sections of Rheumatology, Allergy & Clinical Immunology, Pulmonary Critical Care, Cardiology and Gastroenterology, with an interest and expertise in systemic sclerosis (also called scleroderma), have established a multidisciplinary scleroderma program.

Directed by Monique Hinchcliff, MD, MS, scleroderma patients currently receive comprehensive care at three Yale New Haven Health (YNHHS) sites, the North Haven Interventional Immunology Center, the Winchester Chest Clinic, and 40 Temple Street Clinic in New Haven. Plans are underway to combine the program in one location.

The team provides coordinated, multidisciplinary, and compassionate care for patients with a wide array of scleroderma clinical manifestations—including lung, heart, skin, renal and gastrointestinal involvement—while addressing functional, nutritional, psychological, gynecological, urological, and/or sexual health challenges as well. The goal is improved quality of life, enhanced patient satisfaction, and better outcomes.

Yale has been designated as a Scleroderma Center by the Scleroderma Foundation.

The program will bridge outstanding clinical and basic science research from Yale School of Medicine (YSM) with patient care through YNHHS. Patient-focused research will enable YSM physician-scientists and basic scientists to test hypotheses and generate compelling preliminary data that is essential for planning valid clinical trials. If you have a patient with scleroderma who would benefit from a coordinated, team care approach, please contact the Yale CARE Center at 203-495-2927.

New patients are seen on a referral basis only using the new patient referral form which should be faxed to 203-785-7053 or for patients who are currently seen within the Yale New Haven Health and its partner organizations, a referral must be entered into EPIC by choosing the YNH Arthritis & Rheumatology option.